.svg){kind=small}
Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review ‘ The application of GMP and its role in maximising the benefits of adaptive study design in early phase clinical trials’.
.avif)
Latest news
Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.
December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
